Some of these products are not FDA cleared. Please contact your sales representative for more information.
Product claims may differ from country to country based on regulations and product approvals.
Please contact your country representative for further details.
Do you have an innovative diagnostic biomarker and are looking for a partner for development, production and worldwide distribution?
Do you have - if possible - quantitative and highly sensitive technology which is particularly suitable in the point-of-care field? Our Business Development Department evaluates and implements any potential co-operation and utilisation of your technologies with B·R·A·H·M·S Biomarkers.
From their own basic research B·R·A·H·M·S Biomarkers have developed a number of biomarkers whose suitability for diagnostics, prognosis and therapy monitoring has been confirmed in extensive clinical trials. These biomarkers - mainly from the areas of sepsis and cardiovascular diseases - have the potential to support an effective, patient-specific treatment choice.
You are looking for biomarkers which can be integrated into preclinical and clinical studies and thereby accelerate the development of your therapeutic innovations.